Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Oxford Genetics
company
About
Oxford Genetics is a biotechnology company producing versatile cloning plasmids for research.
- 51 - 100
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- £150K
- Industries
- Biotechnology,Genetics
- Founded date
- Apr 28, 2011
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
£650K
Oxford Genetics has raised a total of
£650K
in funding over 2 rounds. Their latest funding was raised on
Jul 3, 2015 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 3, 2015 | Series Unknown | £500K | 1 |
Mercia Fund Managers
|
— | Detail |
| Jul 30, 2013 | Seed | £150K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Oxford Genetics is funded by 1 investors.
Mercia Fund Managers
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mercia Fund Managers
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
